Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

NCT01148017 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

433

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Sponsor

Novartis Vaccines

Collaborators

[object Object]